Amgen inventory good points on Novo Nordisk’s weightloss drug blunder

Amgen inventory received bigger than 2% in Friday’s morning session after foreign weightloss drug competitor NovoNordisk (NVO) plunged following the outcomes of novel drug attempting out…
Read More